KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2025)

CareDx's Asset Writedowns and Impairment history spans 4 years, with the latest figure at -$2.3 million for Q4 2025.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to -$2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.3 million, a N/A change, with the full-year FY2022 number at $840000.0, down 65.53% from a year prior.
Asset Writedowns and Impairment hit -$2.3 million in Q4 2025 for CareDx, down from -$1.0 million in the prior quarter.
Over the last five years, Asset Writedowns and Impairment for CDNA hit a ceiling of $2.4 million in Q4 2021 and a floor of -$2.3 million in Q4 2025.
Historically, Asset Writedowns and Impairment has averaged $203800.0 across 4 years, with a median of $840000.0 in 2022.